Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Relationship between adverting and sales promotion
Importance of online advertising on sales
Nature of corporate social responsibility
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Relationship between adverting and sales promotion
Initial Success In the year 1980 GlaxoWellcome entered the pharmaceutical industry with their product Zantac, an H2 receptor antagonist. Zantac achieved greater success over competing medications such as Tagamet for various reasons. Zantac seemed an attractive alternative to Tagamet as it was available as a single daily dose that could be taken before going to sleep. Tagamet had to be administered three times a day before meals. Zantac was also slightly more effective than Tagamet in reducing symptoms and suppressing the secretion of stomach acid. The healing speed and healing efficacy were also marginally higher in comparison to Tagamet. (Collen, 1984) The official labelling on Zantacs packaging stated fewer side effects than SmithKline’s Tagamet and Zantac could also be used by children and pregnant woman. Tagamets labelling indicated otherwise. This led many to believe that Glaxowellcomes Zantac was a safer, healthier option. Certain characteristics of a new product affect its rate of adoption. Relative advantage is the degree to which the new product appears better than an existing product (Kotler & Armstrong, 2013). Glaxowellcomes product only needs to be taken once per day and the fact that Zantac required a lower total dose made the product appear more potent and longer acting than competing medications. This added advantage created the perception that Zantac was vastly superior to Tagamet when in fact the differences are minimal in comparison. A customer will always buy from a company that offers the highest customer perceived value. Another key characteristic that influences the rate of spread or diffusion of a new product is complexity. This is the degree to which the new product is easy to understand or use. (Kotler & A... ... middle of paper ... ...and the negative image poor social responsibility creates. Poor corporate social responsibility can be detrimental to the success of any business and this variable often poses a significant threat to large pharmaceutical companies. I would address this issue by investing money into promotional strategies that sponsor and support sustainable practices. Supporting “green” initiatives and appearing environmentally friendly generates positive publicity and a favourable image in the eyes of the consumer. Investing into programmes such as these would display GlaxoWellcome in a positive light and would destroy the negative stigma often attached to companies in the pharmaceutical industry. The implementation of these strategies although costly, may swing consumer preference for the drug and increase market share, brand awareness and the overall profitability of the business
As each product has its own unique segment, target market, and symptoms relief, those differences are going to be essential to promote each product value to prevent cannibalization. Thus the best advertising agency was selected to provide us the best response.
Auton, Frank. “Opinion: The Case for Advertising Pharmaceuticals Directly to Consumers”. Future Medicinal Chemistry. July 2009. http://www.ncbi.nlm.nih.gov/pubmed?term=Auton%20F%5BAuthor%5D&cauthor=true&cauthor_uid=21426028. Web. 20 April 2014.
Market penetration involves with entering a new market with an existing products (Ansoff, 1957). Red Bull can make changes in the products they offer by introducing different flavours and non-caffeine drinks to penetrate the new market. This diversification of products will show their innovative skills to their customers. The company should improve their existing product and use market research, product adaptation analysis, and legal review to seek expansion for the existing products (McDonald,
In Melody Peterson’s “Our Daily Meds” , the history of marketing and advertising in the pharmaceutical industry is explored. The first chapter of the book, entitled “Creating disease”, focuses on how major pharmaceutical companies successfully create new ailments that members of the public believe exist. According to Peterson, the success that these drug manufacturers have experienced can be attributed to the malleability of disease, the use of influencial people to promote new drugs and the efficient usage of media outlets.
Why do consumers purchase specific drugs for various ailments, sicknesses or diseases they might have? Why do physicians prescribe certain drugs over competitive drugs that may be available to the public? Why is it that most of us can easily name specific drugs that fit the many ailments of today’s society? On the surface the answer might be as simple as good TV advertising or radio commercials or even internet adds. The truth of matter is the major pharmaceutical manufacturers own the patents on these drugs and this gives them all of the marketing budget and muscle they need to promote the drug and control the pricing. The incentives for larger pharmaceutical companies are very enticing and as a result, they don’t mind spending the time in clinical trials and patent courts to get their drugs approved. Some will even get patents on the process by which the drug is manufactured, ensuring that no competitor can steal the drug or the process. This protects their large financial investment and nearly guarantees a large return for their investors. Many consumer rights groups claim this is nothing more than legalizing monopolies for the biggest manufacturers.
...s little information about the possible benefits of the study or the side effects. The side effects proved to be significant (gastrointestinal complains, headache, and an elevation of alanine aminotransferase), while the benefits were minimal. This situation emphasizes the need for a balanced approach when it comes to drug clinical trials.
The last of these was the merger between Glaxo Wellcome and SmithKline Beecham, which formed the current company of GlaxoSmithKline. GlaxoSmithKline’s business is to discover effective medicines and healthcare products for people throughout the world and create shareholder value. They are one of the world’s leading producers of prescription medicines, vaccines and consumer healthcare products (Toiletries, Drinks). These products include SEROXAT/PAXIL, AUGMENTIN, WELLBUTRIN and ZOTRAN, all of which are pharmaceutical products. AQUAFRESH, LUCOZADE, NIQUITIN CQ and SENSODYNE, these are known as consumer healthcare products.
As stated in the case, “the market for energy drinks was growing; between 2010 and 2012, the market for energy drinks had grown by 40%. It was estimated to be $8.5 billion in the United States in 2013 [and] forecasts projected that figure to reach $13.5 billion by 2018” (pg 5). However, much of this market’s revenue -- 85% in fact -- is dominated by five major brands, while the remaining 15% is split between approximately 30 regional and national companies. (pg. 5). With this saturated market, it might not be best for Crescent Pure to enter as a completely new product to the industry, as there is the possibility that it will be squeezed out of the profit shares by more established brands -- especially if it is not properly secure in its identity. In addition, while the market for energy drinks appeared to be growing at an exponential rate compared to the market for sports drinks -- which increased only 9% in five years and would be at approximately 60% of the rate for energy drinks in 2017 (pg 6) -- the consumers appeared to be wary of partaking in the market for several reasons, which would potentially harm the reach of Crescent Pure. These concerns included rising news reports discussing the safety of energy drinks (pg. 5). Taking into consideration the data provided in the case that concerns reasonings of why consumers choose specific drinks over others, there
Omeprazole belongs to the family of medications called proton pump inhibitors (PPIs). It slows or prevents the production of acid within the stomach and is used to treat conditions where reduction in acid secretion is required for proper healing including stomach and intestinal ulcers (gastric and duodenal ulcers), the prevention and treatment of ulcers associated with medications known as NSAIDs, reflux oesophagitis, Zollinger-Ellison syndrome, heartburn, and gastro oesophageal reflux disease (GERD). Omeprazole, like other proton-pump inhibitors, blocks the enzyme in the wall of the stomach that produces acid. By blocking the enzyme, the production of acid is decreased, and this allows the stomach and oesophagus to heal. This essay will discuss the therapeutic effect and uses of Omeprazole, its mechanism of action, administration and dosage, dose-related and non-d...
For commodity generic drugs, Teva has an opportunity to expand its core business into emerging markets, but there it will have to face institutional voids because such markets are driven by physicians and both physician and other people are not aware about the effectiveness of generic drugs. To cope with the challenge of institutional voids Teva have to look for some competent small pharmaceutical firms for acquisition and some big firms for the joint venture. For changing the perceptions of people and physicians, Teva will require to run marketing campaigns and direct approaches to physicians to develop a market for their products.
With the pharmaceutical industry constantly changing, it makes it very important for a company to analyze the macro environment. The first force is political; right now that pharmaceutical industry is greatly affected by politicians due to changes in health care structure, healthcare platforms, and partnerships with certain pharmaceutical companies. Within the next three to five years as politicians rotate we can foresee the political force being an even greater impact on the industry. The next force is economic. For the now we feel that the pharmaceutical industry is greatly affected by the economic force as people have more spendable income and will be more likely to purchase brand name drugs. As income dwindles, some poor individuals may be unable to purchase even generic drugs. Within the next three to five years since we are coming out of a recession, we will see consumer spending increase and the demand for the highest quality of medicines increase. The economic force will greatly impact the pharmaceutical industry for some time. The next force of the macro environment is the social force. The social force greatly affects the industry since we have begun to focus on preventative health care and detection recently. Moving forward we expect the trend of preventative health care and our tendency to change our health habits will prompt the pharmaceutical industry to deliver new and innovative products. The fourth force is technological; right now the pharmaceutical industry is greatly impacted by changes in technology, and will continue to be affected for years to come. The next force, ecological, somewhat affects the industry. Events like natural disasters, plagues, and other mass causalities can greatly affect the pharmaceutic...
In today’s world, there are many ways for a company to introduce a new product into the market. Tiger Tread, a new product from the National Chemical Corporation, is a great example. John Webster, marketing director, and Fred Farley, technical director of the company, knew that they had a very special product to introduce.
In this world, creating a new product, as good as it may be, is not enough. The success of any product, in this day and age, depends grandly on the way it is presented to the market. Marketing is responsible in assuring a successful launch of a product, new or reinvented, and to assure its sustainability in this competitive world. For those reasons, billions of dollars are spent each year on tools and strategies to improve marketing research and predict the success of a product: many marketing firms form focus groups, do trials and conduct many tests just to end up with a fairly high percentage of failures.
In this assignment I will reflect on a situation that happened during my first hospital placement. Reflection is a process of making sense out of all life experiences in general and nursing practice in particular (Taylor B 2004). It seeks to describe, analyse, evaluate and therefore inform my learning experience in practice. I have chosen to make sense out of that experience by employing Gibbs’ model (1998) reflective cycle. I will explore the bathing practice used in hospital, and how best the bathing process as a pleasant experience. I knew this practice placement experience would be different from the community placement I had previously experienced. In this clinical setting, as a student I was conditioned to bathe patients first thing every morning. It seemed this was a ritual routine which ward wanted carried out before patients had their breakfast. The system worked well when there were few assisted washes to be done.
Green and sustainable companies has made social responsibility an important part of their business models.